Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
NCT05415228 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2023-05-18
Summary
This is an expanded access program using 68Ga PSMA-HBED-CC (68Ga-PSMA-11).
The primary goal of this expanded access program is to make 68Ga PSMA-11 PET/CT imaging available to patients.
Conditions
- Prostate Adenocarcinoma
Interventions
- DRUG
-
68Ga-PSMA-11
68Ga-PSMA-11 is a radiopharmaceutical for the detection of prostate cancer using PET/CT imaging
Sponsors & Collaborators
-
Morand Piert, MD
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer
NCT04377152 ·Status: APPROVED_FOR_MARKETING
-
68Ga-PSMA-11 PET in Patients With Prostate Cancer
NCT05197257 ·Status: COMPLETED ·Phase: PHASE3
-
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
NCT03396874 ·Status: COMPLETED ·Phase: PHASE2
-
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
NCT03803475 ·Status: COMPLETED ·Phase: PHASE3
-
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
NCT03389451 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management
NCT02810886 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
NCT02918357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
68Ga-PSMA PET/CT in Prostate Cancer
NCT04684628 ·Status: SUSPENDED ·Phase: PHASE3
-
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
NCT04179968 ·Status: COMPLETED ·Phase: PHASE2
-
68 Ga-PSMA for High Risk Prostate Cancer
NCT04614363 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
NCT03822845 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
NCT05034562 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer
NCT04777071 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer
NCT03689582 ·Status: TERMINATED ·Phase: PHASE2
-
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
NCT04484701 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
NCT05002465 ·Status: NO_LONGER_AVAILABLE
-
PSMA PET Imaging of Recurrent Prostate Cancer
NCT03204123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
NCT05324332 ·Status: RECRUITING ·Phase: NA
-
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
NCT05547386 ·Status: COMPLETED ·Phase: PHASE3
-
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
NCT02940262 ·Status: COMPLETED ·Phase: PHASE3
-
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
NCT05847348 ·Status: RECRUITING ·Phase: PHASE3
-
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
NCT04402151 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-PSMA PET/CT in Prostate Cancer
NCT03001869 ·Status: COMPLETED ·Phase: PHASE3
-
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04348682 ·Status: APPROVED_FOR_MARKETING